PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 20, 2004RNA574 citationsOpen Access

In vivo activity of nuclease-resistant siRNAs

JLJuliana M. LayzerAMAnton P. McCaffreyATAlice Tanner

Key Points

Key points are not available for this paper at this time.

Abstract

Chemical modifications have been incorporated into short interfering RNAs (siRNAs) without reducing their ability to inhibit gene expression in mammalian cells grown in vitro. In this study, we begin to assess the potential utility of 2'-modified siRNAs in mammals. We demonstrate that siRNA modified with 2'-fluoro (2'-F) pyrimidines are functional in cell culture and have a greatly increased stability and a prolonged half-life in human plasma as compared to 2'-OH containing siRNAs. Moreover, we show that the 2'-F containing siRNAs are functional in mice and can inhibit the expression of a target gene in vivo. However, even though the modified siRNAs have greatly increased resistance to nuclease degradation in plasma, this increase in stability did not translate into enhanced or prolonged inhibitory activity of target gene reduction in mice following tail vein injection. Thus, this study shows that 2'-F modified siRNAs are functional in vivo, but that they are not necessarily more potent than unmodified siRNAs in animals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Layzer et al. (2004) studied this question.

synapsesocial.com/papers/6a61a1dc2004386bc7d0bd45https://doi.org/10.1261/rna.5239604
Ask AI
Helpful
Bookmark
Share
View Full Paper